Paraganglioma
Oncology·MeSH: Paraganglioma
2 drugs in development·2 companies·5 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Welireg | Merck & Co., Inc. (MRK) |
Phase 3(1)
| Drug | Company |
|---|---|
| ONC206 | Jazz Pharmaceuticals plc (JAZZ) |
Compare drugs
Frequently asked questions
How many drugs are in development for Paraganglioma?
BioSniper tracks 2 drugs in development for Paraganglioma across 2 companies.
How many clinical trials target Paraganglioma?
There are 5 clinical trials targeting Paraganglioma tracked by BioSniper.
Deep-dive into Paraganglioma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis